Molecular viral oncology of hepatocellular carcinoma

被引:389
作者
Block, TM
Mehta, AS
Fimmel, CJ
Jordan, R
机构
[1] Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Jefferson Ctr Biomed Res, Doylestwon, PA 18901 USA
[2] St Louis Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, St Louis, MO 63106 USA
关键词
hepatocellular carcinoma; liver cancer; hepatitis B; hepatitis C;
D O I
10.1038/sj.onc.1206557
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma (HCC) is the fifth most common cancer, but the third leading cause of cancer death, in the world, with more than 500000 fatalities annually. The major etiology of HCC/liver cancer in people is hepatitis B virus (HBV), followed by hepatitis C virus infection (HCV), although nonviral causes also play a role in a minority of cases. Recent molecular studies confirm what was suspected: that HCC tissue from different individuals have many phenotypic differences. However, there are clearly features that unify HCC occurring in a background of viral hepatitis B and C. HCC due to HBV and HCV may be an indirect result of enhanced hepatocyte turnover that occurs in an effort to replace infected cells that have been immunologically attacked. Viral functions may also play a more direct role in mediating oncogenesis. This review considers the molecular and cellular mechanisms involved in primary hepatocellular carcinoma, using a viral perspective.
引用
收藏
页码:5093 / 5107
页数:15
相关论文
共 119 条
  • [81] Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients
    Preikschat, P
    Günther, S
    Reinhold, S
    Will, H
    Budde, K
    Neumayer, HH
    Krüger, DH
    Meisel, H
    [J]. HEPATOLOGY, 2002, 35 (02) : 466 - 477
  • [82] Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection
    Rehermann, B
    Lau, D
    Hoofnagle, JH
    Chisari, FV
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) : 1655 - 1665
  • [83] Mitogen-activated protein kinase pathways
    Robinson, MJ
    Cobb, MH
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) : 180 - 186
  • [84] SCHLESINGER MJ, 1982, J BIOL CHEM, V257, P9887
  • [85] Hepatitis B virus biology
    Seeger, C
    Mason, WS
    [J]. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2000, 64 (01) : 51 - +
  • [86] Target disruption of the mutant β-catenin gene in colon cancer cell line HCT116:: preservation of its malignant phenotype
    Sekine, S
    Shibata, T
    Sakamoto, M
    Hirohashi, S
    [J]. ONCOGENE, 2002, 21 (38) : 5906 - 5911
  • [87] Insights into the pathobiology of hepatitis C virus-associated cirrhosis - Analysis of intrahepatic differential gene expression
    Shackel, NA
    McGuinness, PH
    Abbott, CA
    Gorrell, MD
    McCaughan, GW
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (02) : 641 - 654
  • [88] SHIMODA R, 1994, CANCER RES, V54, P3171
  • [89] Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors
    Shrivastava, A
    Manna, SK
    Ray, R
    Aggarwal, BB
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (12) : 9722 - 9728
  • [90] Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome
    Sirma, H
    Weil, R
    Rosmorduc, O
    Urban, S
    Israël, A
    Kremsdorf, D
    Bréchot, C
    [J]. ONCOGENE, 1998, 16 (16) : 2051 - 2063